JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 114 filers reported holding JOUNCE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.78 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $249 | -79.5% | 135,324 | -87.7% | 0.00% | -83.3% |
| Q4 2022 | $1,217 | -99.9% | 1,097,828 | +37.3% | 0.01% | -40.0% |
| Q3 2022 | $1,869,000 | -24.9% | 799,385 | -2.7% | 0.01% | -23.1% |
| Q2 2022 | $2,489,000 | -55.2% | 821,327 | +0.4% | 0.01% | -43.5% |
| Q1 2022 | $5,555,000 | -25.7% | 818,353 | -8.6% | 0.02% | -17.9% |
| Q4 2021 | $7,474,000 | +13.3% | 895,224 | +0.8% | 0.03% | +12.0% |
| Q3 2021 | $6,598,000 | +37.8% | 888,365 | +26.2% | 0.02% | +38.9% |
| Q2 2021 | $4,787,000 | -3.9% | 703,919 | +45.1% | 0.02% | -5.3% |
| Q1 2021 | $4,982,000 | +28.8% | 485,145 | -12.2% | 0.02% | +26.7% |
| Q4 2020 | $3,868,000 | -44.6% | 552,628 | -35.4% | 0.02% | -48.3% |
| Q3 2020 | $6,977,000 | +4.3% | 855,122 | -11.8% | 0.03% | 0.0% |
| Q2 2020 | $6,690,000 | +47.0% | 969,684 | +1.2% | 0.03% | +11.5% |
| Q1 2020 | $4,551,000 | -23.3% | 958,417 | +41.1% | 0.03% | -3.7% |
| Q4 2019 | $5,932,000 | +324.3% | 679,478 | +61.9% | 0.03% | +350.0% |
| Q3 2019 | $1,398,000 | -24.9% | 419,661 | +11.6% | 0.01% | -33.3% |
| Q2 2019 | $1,862,000 | +3.0% | 376,090 | +29.0% | 0.01% | +12.5% |
| Q1 2019 | $1,807,000 | +283.7% | 291,533 | +108.3% | 0.01% | +300.0% |
| Q4 2018 | $471,000 | +19.2% | 139,957 | +130.6% | 0.00% | 0.0% |
| Q3 2018 | $395,000 | +128.3% | 60,691 | +168.5% | 0.00% | +100.0% |
| Q2 2018 | $173,000 | -91.1% | 22,605 | -74.0% | 0.00% | -87.5% |
| Q1 2018 | $1,941,000 | -37.6% | 86,902 | -64.4% | 0.01% | -38.5% |
| Q4 2017 | $3,112,000 | -37.0% | 243,956 | -23.1% | 0.01% | -40.9% |
| Q3 2017 | $4,942,000 | +109.5% | 317,247 | +88.6% | 0.02% | +100.0% |
| Q2 2017 | $2,359,000 | – | 168,199 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 2,697,829 | $20,045,000 | 88.84% |
| TRV GP III, LLC | 3,048,780 | $22,652,000 | 4.30% |
| Logos Global Management LP | 2,000,000 | $14,860,000 | 1.07% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 208,559 | $1,550,000 | 0.88% |
| PFM Health Sciences, LP | 3,848,822 | $28,597,000 | 0.84% |
| Yorktown Management & Research Co Inc | 113,200 | $841,000 | 0.63% |
| Moloney Securities Asset Management, LLC | 282,250 | $2,097,000 | 0.38% |
| PATHWAY CAPITAL MANAGEMENT, LP | 84,763 | $630,000 | 0.30% |
| Sofinnova Investments, Inc. | 637,347 | $4,735,000 | 0.28% |
| Omega Fund Management, LLC | 275,513 | $2,047,000 | 0.23% |